Blockade of OX40-OX40L Interactions Attenuates Allograft Rejection Mediated by CD4 T Cells That Recognize Alloantigen through the Direct but Not Indirect Pathway of Allorecognition

Blockade of OX40-OX40L Interactions Attenuates Allograft Rejection Mediated by CD4 T Cells That Recognize Alloantigen through the Direct but Not Indirect Pathway of Allorecognition

Библиографические подробности
Главные авторы:	Kinnear, G, Wood, K, Fallah-Arani, F, Jones, N
Формат:	Conference item
Опубликовано:	2012

Схожие документы

A diametric role for OX40 in the response of effector/memory CD4+ T cells and regulatory T cells to alloantigen.
по: Kinnear, G, и др.
Опубликовано: (2013)

Role of OX40-OX40L interactions in the immune response to solid organ allografts
по: Kinnear, G
Опубликовано: (2013)

Anti-OX40 prevents effector T-cell accumulation and CD8+ T-cell mediated skin allograft rejection.
по: Kinnear, G, и др.
Опубликовано: (2010)

An OX-Tra’Ordinary Tale: The Role of OX40 and OX40L in Atopic Dermatitis
по: Kaviyon Sadrolashrafi, и др.
Опубликовано: (2024-03-01)

Uptake of HLA Alloantigens via CD89 and CD206 Does Not Enhance Antigen Presentation by Indirect Allorecognition
по: Eytan Breman, и др.
Опубликовано: (2016-01-01)

Generation and characterization of OX40-ligand fusion protein that agonizes OX40 on T-Lymphocytes
по: Ayaka Sato, и др.
Опубликовано: (2025-01-01)

Increased Expressions of OX40 and OX40 Ligand in Patients with Primary Immune Thrombocytopenia
по: Dawei Cui, и др.
Опубликовано: (2019-01-01)

OX40L blockade is therapeutic in arthritis, despite promoting osteoclastogenesis.
по: Gwyer Findlay, E, и др.
Опубликовано: (2014)

Clinical Significance of OX40 and OX40 Ligand in the Peripheral Blood of Patients with Myasthenia Gravis
по: Xiaoling Zhou, и др.
Опубликовано: (2022-01-01)

OX40-OX40L Inhibition for the Treatment of Atopic Dermatitis—Focus on Rocatinlimab and Amlitelimab
по: Ana Maria Lé, и др.
Опубликовано: (2022-12-01)

OX40 is differentially expressed on activated rat and mouse T cells and is the sole receptor for the OX40 ligand.
по: al-Shamkhani, A, и др.
Опубликовано: (1996)

Roquin recognizes a non-canonical hexaloop structure in the 3′-UTR of Ox40
по: Robert Janowski, и др.
Опубликовано: (2016-03-01)

Research progress on OX40/OX40L axis mediated T cell immunity in the course of oral lichen planus
по: LIU Yang, и др.
Опубликовано: (2022-07-01)

699 A differentiated anti-OX40 agonist BGB-A445 does not block OX40-OX40L interaction and reveals remarkable anti-tumor efficacy in preclinical models
по: Bo Zhang, и др.
Опубликовано: (2020-11-01)

Mast Cell-Derived Exosomes Promote Th2 Cell Differentiation via OX40L-OX40 Ligation
по: Fei Li, и др.
Опубликовано: (2016-01-01)

Analysis of the OX40/OX40L immunoregulatory axis combined with alternative immune checkpoint molecules in pancreatic ductal adenocarcinoma
по: Xianlong Chen, и др.
Опубликовано: (2022-07-01)

Immune Checkpoints OX40 and OX40L in Small-Cell Lung Cancer: Predict Prognosis and Modulate Immune Microenvironment
по: Peixin Chen, и др.
Опубликовано: (2021-11-01)

Breaking Immunological Tolerance through OX40 (CD134)
по: Pratima Bansal-Pakala, и др.
Опубликовано: (2001-01-01)

OX40L/OX40 Signal Promotes IL-9 Production by Mucosal MAIT Cells During Helicobacter pylori Infection
по: Siqi Ming, и др.
Опубликовано: (2021-03-01)

OX40-OX40L interaction promotes proliferation and activation of lymphocytes via NFATc1 in ApoE-deficient mice.
по: Jinchuan Yan, и др.
Опубликовано: (2013-01-01)

Development of OX40 agonists for canine cancer immunotherapy
по: Damien Ruiz, и др.
Опубликовано: (2022-10-01)

CD40-CD40 ligand-independent activation of CD8+ T cells can trigger allograft rejection.
по: Jones, N, и др.
Опубликовано: (2000)

CD40-CD40L independent activation of CD8+T cells can trigger allograft rejection.
по: Jones, N, и др.
Опубликовано: (2000)

A Narrative Review of the OX40-OX40L Pathway as a Potential Therapeutic Target in Atopic Dermatitis: Focus on Rocatinlimab and Amlitelimab
по: Asaad Abdelhalim, и др.
Опубликовано: (2024-11-01)

Relationship between bladder cancer and polymorphisms of OX40 (rs17568) and OX40L (rs1234313) genes in a Turkish population
по: Osman Bilen, и др.
Опубликовано: (2023-03-01)

Enhancement of the Soluble Form of OX40 and OX40L Costimulatory Molecules but Reduction of the Membrane Form in Type 1 Diabetes (T1D)
по: Jingnan An, и др.
Опубликовано: (2019-01-01)

Lymphatic Reconstruction in Kidney Allograft Aggravates Chronic Rejection by Promoting Alloantigen Presentation
по: Jinwen Lin, и др.
Опубликовано: (2021-12-01)

Dual anti-OX40/IL-2 therapy augments tumor immunotherapy via IL-2R-mediated regulation of OX40 expression.
по: William L Redmond, и др.
Опубликовано: (2012-01-01)

Ox-LDL increases OX40L in endothelial cells through a LOX-1-dependent mechanism
по: Q. Dong, и др.
Опубликовано: (2013-09-01)

OX40 is required for regulatory T cell-mediated control of colitis.
по: Griseri, T, и др.
Опубликовано: (2010)

OX40 facilitates control of a persistent virus infection.
по: Tobias Boettler, и др.
Опубликовано: (2012-09-01)

OX40 agonists and combination immunotherapy: putting the pedal to the metal
по: Stefanie N Linch, и др.
Опубликовано: (2015-02-01)

Tissue specific deletion of inhibitor of kappa B kinase 2 with OX40-Cre reveals the unanticipated expression from the OX40 locus in skin epidermis.
по: Georgina H Cornish, и др.
Опубликовано: (2012-01-01)

Corrigendum: Lymphatic reconstruction in kidney allograft aggravates chronic rejection by promoting alloantigen presentation
по: Jinwen Lin, и др.
Опубликовано: (2022-11-01)

OX40 stimulation enhances protective immune responses induced after vaccination with attenuated malaria parasites
по: Othman, A, и др.
Опубликовано: (2018)

OX40 Stimulation Enhances Protective Immune Responses Induced After Vaccination With Attenuated Malaria Parasites
по: Ahmad Syibli Othman, и др.
Опубликовано: (2018-07-01)

Affinity and kinetics of the interaction between soluble trimeric OX40 ligand, a member of the tumor necrosis factor superfamily, and its receptor OX40 on activated T cells.
по: Al-Shamkhani, A, и др.
Опубликовано: (1997)

Inhibition of chronic rejection and development of tolerogenic T cells after ICOS-ICOSL and CD40-CD40L co-stimulation blockade.
по: Brook, M, и др.
Опубликовано: (2005)

Association of OX40L gene polymorphism with multiple sclerosis in Iranians
по: Abdolreza Sotoodeh Jahromi, и др.
Опубликовано: (2024-03-01)

Structural Basis of a Novel Agonistic Anti-OX40 Antibody
по: Jing Zhang, и др.
Опубликовано: (2022-08-01)